// App-Quantinova.ai

1200 : HER-2 isoform interaction in mammary carcinoma onset and progression

Researchers

Presenter

  • Arianna Palladini

Principal Investigators

  • Massimiliano Dall Ora

  • Tania Balboni

  • Giordano Nicoletti

  • Marianna Ianzano

  • Roberta Laranga

  • Lorena Landuzzi

  • Veronica Giusti

  • Alessia Lamolinara

  • Carla De Giovanni

  • Augusto Amici

  • Serenella M. Pupa

  • Manuela Iezzi

  • Patrizia Nanni

  • Pier-Luigi Lollini

Medical Centers

  • Rizzoli Orthopaedic Institute, Bologna, Italy

  • Aging Research Centre, Gabriele dAnnunzio University, Chieti, Italy

  • University of Palermo, Palermo, Italy

  • Istituto Nazionale Tumori, Milano, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mammary carcinoma

  • Breast cancer

  • Solid malignancies

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

  • Kinase Insert Domain Receptor

  • Vascular endothelial growth factor A

Drug/Treatment

  • Trastuzumab

  • Neratinib

  • Lapatinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved